BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/19/2026 6:51:57 AM | Browse: 0 | Download: 0
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 127166
Country Ireland
Received
2026-08-24 11:00
Peer-Review Started
2026-08-24 11:00
First Decision by Editorial Office Director
Return for Revision
2026-09-10 12:37
Revised
2026-09-13 13:33
Publication Fee Transferred
Editorial Processing by Scientific Editor
2026-10-09 03:30
Final Academic Decision by Editor-in-Chief
Publication Technical Verification by Editorial Office Director
2026-10-09 09:30
Articles in Press
2026-10-09 09:30
Edit the Manuscript by Language Editor
Typeset the Manuscript
2026-10-21 09:54
Publish the Manuscript Online
2026-11-19 06:51
ISSN 1948-5204 (online)
Open Access This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Copyright ©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Minireviews
Article Title Sporadic diffuse gastric cancer in Western populations and the mismatch between tumour biology and clinical care
Manuscript Source Invited Manuscript
All Author List Eoghan Burke
ORCID
Author(s) ORCID Number
Eoghan Burke http://orcid.org/0000-0001-9809-9405
Funding Agency and Grant Number
Corresponding Author Eoghan Burke, Consultant, FRCS (Gen Surg), Principal Investigator, Researcher, Department of upper Gastrointestinal Surgery, Beaumont Hospital, Beaumont Hospital, Dublin, Ireland, Dublin 12345, Ireland. eoghanburke@rcsi.ie
Key Words Diffuse-type gastric cancer; Poorly cohesive carcinoma; Gastric carcinogenesis; Gastric atrophy; Molecular biomarkers; Systemic therapy; Immunotherapy; Peritoneal metastasis; Staging laparoscopy
Core Tip VPopulation growth and ageing may increase Western gastric cancer case numbers, while historical registry data suggest a changing relative contribution of diffuse disease. Sporadic diffuse cancer lacks a validated precursor and can evade diagnosis. Its enrichment for genomically stable biology, lower human epidermal growth factor receptor 2 positivity and less frequent mismatch-repair deficiency complicate systemic-treatment selection, while programmed death-ligand 1 expression remains variable. Histological subgroup analyses incompletely define treatment benefit, making individual biomarker testing and better therapeutic evidence essential. Peritoneal tropism adds a further challenge, requiring regional chemotherapy and surgery to be tested separately alongside systemic care. These connected gaps demand a subtype-specific response to the changing burden.
Publish Date 2026-11-19 06:51
Citation

Burke E. Sporadic diffuse gastric cancer in Western populations and the mismatch between tumour biology and clinical care. World J Gastrointest Oncol 2026; 18(12): 127166

URL https://www.wjgnet.com/1948-5204/full/v18/i12/127166.htm
DOI https://doi.org/10.4251/wjgo.127166
Full Article (PDF) WJGO-18-127166-with-cover.pdf